We are live on ! Find out more
GHA

GW Henssler & Associates Portfolio holdings

AUM $2.25B
1-Year Est. Return 19.46%
This Fund
S&P 500
This Quarter Est. Return
+6.76%
1 Year Est. Return
+19.46%
3 Year Est. Return
+62.37%
5 Year Est. Return
+80.78%
10 Year Est. Return
+246.91%
AUM
$1.07B
AUM Growth
+$73.1M
Cap. Flow
+$14.8M
Cap. Flow %
1.38%
Top 10 Hldgs %
28.89%
Holding
151
New
15
Increased
70
Reduced
47
Closed
8

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$12.5M
2
GSK icon
GSK
GSK
+$8.54M
3
SCG
Scana
SCG
+$4.1M
4
MSFT icon
Microsoft
MSFT
+$813K
5
MO icon
Altria Group
MO
+$565K

Sector Composition

Rank Sector Weight
1 Healthcare 12.56%
2 Financials 10.72%
3 Technology 10.46%
4 Consumer Staples 8.74%
5 Industrials 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNW icon
76
Pinnacle West Capital
PNW
$12.2B
$3.63M 0.34%
+42,661
New +$3.77M
UL icon
77
Unilever
UL
$136B
$3.2M 0.3%
51,418
+3,262
+7% +$207K
NSC icon
78
Norfolk Southern
NSC
$75.1B
$3.14M 0.29%
21,651
+453
+2% +$60.8K
KO icon
79
Coca-Cola
KO
$375B
$2.87M 0.27%
62,476
+1,763
+3% +$81K
AET
80
DELISTED
Aetna Inc
AET
$2.83M 0.26%
15,671
-1,122
-7% -$193K
SCHX icon
81
Schwab US Large- Cap ETF
SCHX
$74.5B
$2.58M 0.24%
243,090
+10,086
+4% +$104K
VZ icon
82
Verizon
VZ
$196B
$2.42M 0.23%
45,701
+3,416
+8% +$168K
ETN icon
83
Eaton
ETN
$174B
$2.31M 0.22%
29,170
+1,675
+6% +$130K
CHD icon
84
Church & Dwight Co
CHD
$24.5B
$2.02M 0.19%
40,288
-2,133
-5% -$100K
SCHF icon
85
Schwab International Equity ETF
SCHF
$68.7B
$1.91M 0.18%
112,356
+3,950
+4% +$67.2K
VUG icon
86
Vanguard Morningstar Growth ETF
VUG
$231B
$1.56M 0.15%
66,510
+4,578
+7% +$105K
VYM icon
87
Vanguard High Dividend Yield ETF
VYM
$82.8B
$1.49M 0.14%
17,426
+1,378
+9% +$115K
SCHG icon
88
Schwab US Large-Cap Growth ETF
SCHG
$62.8B
$1.38M 0.13%
156,248
+4,416
+3% +$38K
SCHV
89
Schwab US Large-Cap Value ETF
SCHV
$16.1B
$1.35M 0.13%
73,860
+2,604
+4% +$46.3K
ACN icon
90
Accenture
ACN
$108B
$1.16M 0.11%
7,598
-86,150
-92% -$12.5M
SPY icon
91
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$1.16M 0.11%
4,347
-887
-17% -$231K
DVY icon
92
iShares Select Dividend ETF
DVY
$23.6B
$1.15M 0.11%
11,691
+233
+2% +$22.4K
SCHM icon
93
Schwab US Mid-Cap ETF
SCHM
$15.1B
$1M 0.09%
56,556
+2,217
+4% +$38.3K
BRK.B icon
94
Berkshire Hathaway Class B
BRK.B
$1.13T
$921K 0.09%
4,647
-116
-2% -$22K
FBIN icon
95
Fortune Brands Innovations
FBIN
$6.06B
$814K 0.08%
13,911
T icon
96
AT&T
T
$163B
$728K 0.07%
24,805
-2,183
-8% -$59.6K
TFC icon
97
Truist Financial
TFC
$64B
$714K 0.07%
14,353
-603
-4% -$29.1K
VIG icon
98
Vanguard Dividend Appreciation ETF
VIG
$114B
$704K 0.07%
6,900
+535
+8% +$52.7K
SCHA icon
99
Schwab U.S Small- Cap ETF
SCHA
$23.1B
$699K 0.07%
40,108
+1,152
+3% +$19.7K
VAR
100
DELISTED
Varian Medical Systems, Inc.
VAR
$698K 0.07%
6,280
-39
-0.6% -$4.19K

Similar funds

GW Henssler & Associates's Q4 2017 Portfolio in Review

As of Q4 2017, GW Henssler & Associates held 151 positions worth $1.07B, up 7.3% from $997M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

GW Henssler & Associates's Q4 2017 filing shows 15 new, 70 increased, 47 reduced and 8 closed positions. Its largest new stake was Perrigo: 67,391 shares worth $5.87M. The largest sale was Accenture, an estimated $12.5M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Technology.

  • GW Henssler & Associates's largest Q4 2017 buy was Perrigo: 67,391 shares worth $5.87M.
  • GW Henssler & Associates added most to Royal Dutch Shell PLC ADS Class A in Q4 2017, an estimated $4.18M increase.
  • GW Henssler & Associates's biggest Q4 2017 reduction was Accenture, cutting an estimated $12.5M.
  • GW Henssler & Associates fully exited GSK in Q4 2017, selling an estimated $8.54M.
  • GW Henssler & Associates's ten largest holdings make up 29% of its $1.07B portfolio in Q4 2017.
  • GW Henssler & Associates opened 15 new positions and closed 8 in Q4 2017.
  • GW Henssler & Associates's portfolio value rose 7.3% quarter-over-quarter to $1.07B.

Based on GW Henssler & Associates's 13F filing for Q4 2017, filed 6 Feb 2018.